Overview
Pharmaceutical

KYORIN Pharmaceutical Co.,Ltd.

Kyorin Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing, and sales of prescription and healthcare medicines. The company focuses on addressing unmet medical needs, with therapeutic areas including respiratory diseases (e.g., chronic cough), infectious diseases (e.g., tuberculosis), and other conditions. Kyorin markets products directly to healthcare professionals while also offering consumer healthcare products such as sterilization solutions (e.g., Milton CP).

Market Cap
¥64.6B
US$412M
EV
¥53.9B
US$343M
Stock¥1,125▼-0.53%
US$1 = ¥157.05 (2026-10-22)
LTM EV/EBITDA
7.9
x
LTM EV/EBIT
24.9
x
LTM PER
29.8
x
LTM PBR
0.5
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-44.3%pt
1001
Oct 23, 25 – Oct 23, 26StockTOPIX
1Jul 31, 26Q1 FY2027/03 earnings announced
MC → EV Bridge
64.6BUS$412MMarket Cap23.7BUS$151M+ Debt13.7BUS$87.0M− Cash20.7BUS$132M− Inv. Sec.53.9BUS$343MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
106US$672M'22/3113US$721M'23/3120US$761M'24/3130US$828M'25/3126US$804M'26/3
EBITDA 5Y (¥B)
8.72US$55.5M'22/38.96US$57.1M'23/310.3US$65.6M'24/317.2US$109M'25/38.23US$52.4M'26/3
Net Income 5Y (¥B)
3.93US$25.0M'22/34.72US$30.1M'23/35.32US$33.9M'24/39.09US$57.9M'25/33.45US$22.0M'26/3
Capital Structure
86%
EquityD/E 0.17xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
52.7US$336M21.6US$138M'22/342.4US$270M21.3US$135M'23/336.0US$229M20.9US$133M'24/335.1US$223M28.4US$181M'25/330.7US$195M23.8US$151M'26/3
Shareholders
Top 10 hold 47.4%
1
The Master Trust Bank of Japan, Ltd. (Trust Account)
10.41%
2
Mycam Co., Ltd.
8.90%
3
Lucius Co., Ltd.
4.84%
4
Custody Bank of Japan, Ltd. (Trust Account)
3.79%
5
Stock Ownership Association
3.59%
6
BBH FOR THE ADVISORS' INNERCIRCLE FUND II / KOPERNIK GLO ALL-CAP FUND (Standing Proxy: Mitsubishi UFJ Bank, Ltd., Settlement Business Division)
3.43%
7
Banrina Co., Ltd.
3.35%
8
Archans Co., Ltd.
3.35%
9
Ruches Co., Ltd.
3.02%
10
KAKEN PHARMACEUTICAL CO.,LTD.
2.75%
Management
13 officers
Yutaka OGIHARA
Representative Director, President
Apr 1990 Joined Kyorin Pharmaceutical Co., Ltd. Jun 2011 Manager, Corporate Strategy Office, the Company Jun 2011 Director, Manager, Corporate Strategy Office; in charge of Corporate Communications and Group IT Systems, the Company Jun 2014 Director, Kyorin Pharmaceutical Co., Ltd. Jun 2015 Director, Manager, Corporate Strategy Office, the Company Jun 2016 Managing Director, Manager, Corporate Strategy Office, the Company Jun 2016 Managing Director, Kyorin Pharmaceutical Co., Ltd. Apr 2019 Managing Director, Manager, Corporate Strategy Office; in charge of Group IT Systems, the Company Jun 2019 Representative Director, President; in charge of Group Internal Audit Office, the Company Jun 2019 Director, Kyorin Pharmaceutical Co., Ltd. Apr 2023 Representative Director, President, CEO; in charge of Internal Audit Office, the Company Apr 2026 Representative Director, President and Executive Officer, CEO; in charge of Internal Audit Office, the Company (current)
1967-07-14
Yasushi KUROSE
Director
Apr 1995 Joined Kyorin Pharmaceutical Co., Ltd. Apr 2019 Manager, Corporate Planning Department, Corporate Strategy Office, the Company Jun 2019 General Manager, Group Corporate Planning Division, the Company Apr 2020 General Manager, Group Corporate Planning Division, the Company Apr 2020 General Manager, Corporate Planning Department, Kyorin Pharmaceutical Co., Ltd. Jun 2022 Executive Officer, General Manager, Group Corporate Planning Division, the Company Apr 2023 Executive Officer, CFO & CStO, General Manager, Corporate Planning Department; in charge of Accounting & Finance Department and Product Strategy Department, the Company Jun 2024 Director, CFO & CStO, General Manager, Corporate Planning Department; in charge of Accounting & Finance Department and Product Strategy Department, the Company Apr 2026 Director, Managing Executive Officer, CFO & CStO, General Manager, Corporate Planning Department; in charge of Accounting & Finance Department and Drug Discovery Innovation Promotion Department, the Company (current)
1970-07-27
Ken SHIGEMATSU
Outside Director
Apr 1971 Joined Mitsukoshi Ltd. Mar 1991 President, Mitsukoshi U.S.A. Mar 1997 General Manager, International Business Division, Mitsukoshi Ltd. Mar 1998 General Manager, Merchandise Planning Department, Sales Headquarters, Mitsukoshi Ltd. Mar 1999 Executive Officer, General Manager, Merchandise Planning Department, Sales Headquarters, Mitsukoshi Ltd. May 2002 Director, Executive Officer, Deputy General Manager, Sales Headquarters, Mitsukoshi Ltd. Mar 2004 Director, Managing Executive Officer, General Manager, Merchandise Headquarters, Mitsukoshi Ltd. Mar 2005 Director, Managing Executive Officer, Store Manager, Ginza Store, Mitsukoshi Ltd. Apr 2008 Managing Executive Officer, Isetan Mitsukoshi Holdings Ltd.; Director, Mitsukoshi Ltd. Apr 2009 Director, Senior Managing Executive Officer, Special Assignment, Mitsukoshi Ltd. Apr 2010 Senior Managing Executive Officer, Isetan Mitsukoshi Holdings Ltd.; Representative Director, President, Nagoya Mitsukoshi, Ltd. Oct 2011 Representative Director, President, Endo Seisakusho Co., Ltd. Oct 2015 Representative Director, President, MFSJ Co., Ltd. Jun 2017 Outside Director, the Company (current)
1948-11-15
Hiromi WATANABE
Outside Director
Apr 1972 Joined Department of Internal Medicine, Tokyo Women's Medical University Hospital Apr 1998 Associate Professor, Department of Internal Medicine, Tokyo Women's Medical University School of Nursing Apr 2007 Professor and Dean, School of Medical Sciences, Shukutoku University School of Nursing Apr 2010 Director, Daijo Shukutoku Gakuen Educational Corporation Apr 2011 Professor, School of Medical Sciences, Shukutoku University School of Nursing and Nutrition Nov 2014 President, Tokyo Branch Federation, Japan Medical Women's Association (current) Apr 2016 Professor, Graduate School of Nursing, Shukutoku University Apr 2018 Neurologist, Hospital, Obu Health and Medical Center for the Elderly (current) Jun 2018 Director, NPO 3.11 Thyroid Cancer Children's Fund (current) Jun 2019 Outside Director, the Company (current) Apr 2021 Director, Daijo Shukutoku Gakuen Educational Corporation (current) Oct 2021 Deputy Director, Shimotakaido Station Clinic Mimihanano Plus (current)
1947-07-23
Noriaki TAMURA
Director
Apr 1988 Joined Kyorin Yakuhin Co., Ltd. Apr 2013 General Manager, Sales Division, Sales Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2015 Manager, Kanetsu Branch, East Japan Area Division, Pharmaceutical Sales Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2017 General Manager, Sales Management Department, Pharmaceutical Sales Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2020 General Manager, Group General Affairs & Human Resources Division, the Company Apr 2021 Executive Officer, Deputy Head, Pharmaceutical Sales Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2022 Executive Officer, Head, Pharmaceutical Sales Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2023 Executive Officer, CCO, Head, Pharmaceutical Sales Headquarters; in charge of Information Systems Department and Diagnostics Business Division, the Company Apr 2026 Managing Executive Officer, CCO, Head, Pharmaceutical Sales Headquarters; in charge of IT Solutions Department and Diagnostics Business Division, the Company (current)
Tomohiro OKANOYA
Director
Apr 1986 Registered as attorney-at-law Apr 1986 Joined Kawamura Law Office (current) Apr 1993 Part-time Lecturer, Faculty of Law, Keio University Apr 2005 Audit & Supervisory Board Member, Japan Real Estate Investment Corporation Apr 2012 Professor, Graduate School of Law, Keio University
Tomiharu MATSUMOTO
Full-time Corporate Auditor
Apr 1976 Joined Kyorin Yakuhin Co., Ltd. Apr 2001 Plant Manager, Nogi Plant, Kyorin Pharmaceutical Co., Ltd. Apr 2005 Executive Officer, General Manager, General Affairs & Human Resources Department, Kyorin Pharmaceutical Co., Ltd. Mar 2006 Executive Officer, General Manager, General Affairs & Human Resources Department, the Company Jun 2007 Director, Executive Officer, General Manager, General Affairs & Human Resources Department, Kyorin Pharmaceutical Co., Ltd. Jun 2008 Director, Executive Officer, General Manager, General Affairs & Human Resources Department, the Company Jun 2012 Managing Director, General Manager, Group General Affairs & Human Resources Division, the Company Jun 2012 Managing Director, Kyorin Pharmaceutical Co., Ltd. Jun 2016 Senior Managing Director, General Manager, Group General Affairs & Human Resources Division, the Company Jun 2016 Senior Managing Director, Kyorin Pharmaceutical Co., Ltd. Jun 2018 Full-time Corporate Auditor, the Company (current) Jun 2018 Corporate Auditor, Kyorin Pharmaceutical Co., Ltd. Jun 2018 Corporate Auditor, Kyorin Pharmaceutical Group Plant Co., Ltd. (current)
1953-08-13
Kenji AKUTSU
Full-time Corporate Auditor
Apr 1978 Joined Kyorin Pharmaceutical Co., Ltd. Feb 2001 President and Representative Director, Kyorin USA, Inc. Apr 2004 Manager, Business Development Office, and General Manager, Legal Department, Kyorin Pharmaceutical Co., Ltd. Jun 2009 Executive Officer, Manager, Product Strategy Office, Kyorin Pharmaceutical Co., Ltd. Apr 2014 Executive Officer, General Manager, Development Management Department, Kyorin Pharmaceutical Co., Ltd. Apr 2015 President and Representative Director, Kyorin Medical Supply Co., Ltd. Apr 2015 Executive Officer, the Company Jun 2016 Director, the Company Apr 2017 Director, General Manager, Group General Affairs & Human Resources Division, the Company Apr 2017 General Manager, Human Resources Department, Kyorin Pharmaceutical Co., Ltd. Jun 2017 Director, General Manager, Human Resources Department, Kyorin Pharmaceutical Co., Ltd. Jun 2019 Managing Director, Kyorin Pharmaceutical Co., Ltd. Jun 2019 Managing Director, General Manager, Group General Affairs & Human Resources Division, the Company Jun 2021 Corporate Auditor, Kyorin Remedio Co., Ltd. (current) Jun 2022 Full-time Corporate Auditor, the Company (current)
1956-03-25
Takahisa YAMAGUCHI
Outside Corporate Auditor
Oct 1981 Joined Chuo Audit Corporation Feb 1985 Registered as Certified Public Accountant Sep 1987 Joined Yamaguchi CPA Office Dec 1987 Registered as Certified Tax Accountant Jan 1996 Head, Yamaguchi CPA Office (current) Jun 2013 President, Chiyoda Branch, Japanese Institute of Certified Public Accountants, Tokyo Jun 2013 Outside Corporate Auditor, Sato Holdings Corporation Jun 2015 Outside Corporate Auditor, the Company (current) Mar 2016 Outside Corporate Auditor, Tokyo Tatemono Co., Ltd. Mar 2019 Outside Corporate Auditor, Lion Corporation
1954-09-13
Yukio IKEMURA
Outside Corporate Auditor
Apr 1981 Joined Fuji Bank, Ltd. Mar 2004 Head, European Funding Office, ALM Department, Mizuho Corporate Bank, Ltd. Apr 2008 General Manager, Kabutocho Securities Sales Department, Mizuho Corporate Bank, Ltd. Apr 2009 Executive Officer, Mizuho Securities Co., Ltd. Apr 2010 Executive Officer, NSK Ltd. Jun 2011 Executive Officer, NSK Ltd. Jun 2013 Managing Executive Officer, Head of CSR Division, NSK Ltd. Jun 2018 President and Representative Director, Osaki Redevelopment Building Co., Ltd. Jun 2022 Outside Corporate Auditor, Ogaki Kyoritsu Bank, Ltd. (current) Jun 2022 Outside Corporate Auditor, the Company (current)
1958-02-25
Kensuke MORITA
Outside Corporate Auditor
Apr 1991 Registered as attorney-at-law (Tokyo Bar Association) Apr 1991 Joined Otani Law Office Apr 1996 Attached to Legal Training and Research Institute, Supreme Court of Japan Apr 1998 Established Morita Kensuke Law Office Apr 2002 Co-founded Apollo Law Office (current) Apr 2009 Instructor, Legal Training and Research Institute, Supreme Court of Japan May 2009 Councillor, Chuo University Nov 2010 Part-time Director, General Incorporated Foundation Anshin Foundation (current) Apr 2012 Professor, Department of Business Sciences, University of Tsukuba (current) May 2015 Vice Chairman, Law School Center, Japan Federation of Bar Associations Jun 2022 Outside Corporate Auditor, the Company (current) Nov 2025 Councillor, Chuo University (current)
1966-03-22
Kazuhiro HAMADA
Corporate Auditor
Apr 1984 Joined Kyorin Pharmaceutical Co., Ltd. Apr 2009 General Manager, Development Department II, Clinical Development Center, Research & Development Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2017 General Manager, Medical Affairs Department, Clinical Development Center, Drug Discovery Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2020 Deputy Head, Reliability Assurance Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2021 Executive Officer, Head, Reliability Assurance Headquarters, Kyorin Pharmaceutical Co., Ltd. Apr 2023 Executive Officer, Head, Reliability Assurance Headquarters, the Company
Yutaka ABE
Corporate Auditor
Apr 1984 Joined Fuji Bank, Ltd. Apr 2010 General Manager, International Business Department, Mizuho Bank, Ltd. Dec 2012 Senior Advisor, Hanoi Branch, Mizuho Corporate Bank, Ltd. (Vice Chairman, Vietcombank) Apr 2014 Senior Advisor, Head of International Unit, Executive Officer, Mizuho Bank, Ltd. Jun 2017 Managing Executive Officer, JUKI Corporation Jan 2018 President, JUKI Singapore Pte. Ltd. Jan 2021 President, Executive Director, JUKI (China) Investment Co., Ltd. Jan 2024 Chairman, JUKI Central Europe; Chairman, JAS GmbH Jun 2025 Adviser, JUKI Corporation (current)
Large Shareholding Reports
Show-Chans Co., Ltd.
2026-08-05
5.91%
Kopernik Global Investers, LLC
2026-05-11
7.64%→8.75%
Kopernik Global Investers, LLC
2025-12-22
8.75%→7.64%
Mycam Co., Ltd.
2025-08-05
7.65%→8.64%
Annual report (as of 2026-03-31): 8.90%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-08-05
Large Shareholding Report
TDnet
2026-07-30
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-18
Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2026-05-28
株主総会招集通知
EDINET
2026-05-11
Large Shareholding Report
TDnet
2026-02-04
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-12-22
Large Shareholding Report
EDINET
2025-11-13
Semi-Annual Securities Report
Period: Apr 2025 – Sep 2025
EDINET
2025-08-05
Large Shareholding Report
TDnet
2025-07-31
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-19
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-05
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-13
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-07-31
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-24
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-14
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-14
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-09
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-26
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-14
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-14
Quarterly Securities Report
EDINET
2022-08-09
Quarterly Securities Report
EDINET
2022-06-24
Annual Securities Report
EDINET
2022-02-14
Quarterly Securities Report
EDINET
2021-11-12
Quarterly Securities Report
EDINET
2021-08-10
Quarterly Securities Report
EDINET
2021-06-21
Annual Securities Report
EDINET
2021-02-15
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →